Emami Q1 FY27 Earnings Call — Analysis (NSE: EMAMILTD)
Strategic investments portfolio surges 61% like-to-like to ₹160 Cr, contributing 18% of domestic business, while consolidated revenue grows 15% to ₹1,039 Cr despite margin pressure from commodity inflation and business mix.
Result quality: stable — Steady quarter. Management sentiment: optimistic.
The take
Q1FY27 Consolidated Revenue ₹1,039 Cr ( +15% YoY ) . New guidance — FY27 strategic investments portfolio… ₹750-800 Cr . New story: Strategic investments as new growth engine .
Results
Q1FY27 consolidated revenue ₹1,039 Cr +15% YoY; EBITDA ₹226 Cr +6% YoY; PAT ₹137 Cr -16% YoY due to tax normalisation; gross margin impacted by 360 bps input cost rise (200 bps West Asia conflict, 160 bps mix).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated Revenue | ₹1,039 Cr | +15% | yoy · Q1FY27 |
| Domestic Revenue Growth (reported) | 20% | +20% | yoy · Q1FY27 · domestic business |
| Domestic Revenue Growth (like-to-like) | 12% | +12% | yoy · Q1FY27 · excl. Axiom and IncNut |
| Domestic Volume Growth (like-to-like) | 8% | +8% | yoy · Q1FY27 · excl. Axiom and IncNut |
| EBITDA | ₹226 Cr | +6% | yoy · Q1FY27 |
| Profit Before Tax | ₹195 Cr | +4% | yoy · Q1FY27 |
| Profit After Tax | ₹137 Cr | -16% | yoy · Q1FY27 |
| Input Cost Increase | 360 bps | +360 bps | yoy · Q1FY27 · of which 200 bps West Asia conflict, 160 bps business mix |
| Strategic Investments Revenue | ₹160 Cr | +61% | yoy · Q1FY27 · like-to-like |
Guidance
Strategic investments portfolio FY27 revenue target ₹750–800 Cr; management expects to more than offset absolute input cost increase through pricing actions during the year.
What management committed to
- The strategic investments portfolio will end FY27 at anywhere between ₹750 crores to ₹800 crores of revenue. — ₹750-800 Cr, FY27
- Management expects to more than offset the absolute increase in input cost during FY27 through further pricing actions. — FY27
- The next few quarters should be relatively better than Q1FY27 in terms of profitability. — Q2FY27-Q4FY27
- International business will see significant growth in the third and fourth quarter after realigning strategies. — significant growth, Q3FY27 and Q4FY27
- Kesh King portfolio will deliver double-digit growth for FY27. — double-digit, FY27
- Supply chain planning, Sales code AI, and the analytical hub initiatives will be completed during FY27. — FY27
- Effective tax rate for FY27 will be around 25-26%. — 25-26%, FY27
Key themes
Strategic investments scaling and margin resilience
How the narrative shifted
- Strategic investments as new growth engine: The 61% like-to-like growth of the strategic investments portfolio to ₹160 Cr, now 18% of domestic business, validates the repeatable acquisition model and platform for future roll-ups.
- Core brand resilience and recovery: Hair & scalp care grew 11%, Navratna and 7 Oils strong; skin care recovery expected with Talc returning to FY25 levels; Kesh King turnaround to double-digit growth by year-end.
- Commodity inflation and margin defence: 360 bps input cost rise, partly from West Asia conflict and partly mix, is being fought with measured price increases; management confident of fully offsetting absolute cost increase in FY27 and margin improvement in coming quarters.
- International business disruption and H2 rebound: 12% decline in Q1 due to OTC shipment block; strategies realigned, approval process underway, and “significant growth” expected from Q3/Q4.
- Channel mix shift and quick commerce penetration: Organised channels grew 19% like-to-like to 32% of domestic business; quick commerce now 35% of e-com, reflecting structural demand shift and strong omnichannel execution.
- Operational transformation through AI and analytics: Supply chain planning, Sales code AI and analytical hub to be completed in FY27, aimed at forecasting, sales productivity and data-driven decisions.
Operational commentary
- Strategic investments portfolio grew 61% like-to-like to ₹160 Cr, now 18% of domestic business; all four subsidiaries grew substantially in volume and value.
- Channel transformation: organised channels grew 19% like-to-like, now 32% of domestic business; quick commerce 35% of e-com.
- Supply chain planning, Sales code AI and analytical hub initiatives progressing well; expected to complete in FY27 to improve forecast accuracy, sales productivity and data-driven decisions.
- Hair & Scalp care category grew 11%, led by Navratna Cool Oil (double-digit) and 7 Oils in One (robust growth); Kesh King mid-single-digit, with double-digit expected by year-end.
- International business declined 12% due to West Asia conflict disrupting OTC pain management shipments; management expects significant growth in H2 after realigning strategies.
- Skin care grew 3% (Talc high single-digit, Male grooming and BoroPlus low single-digit); Healthcare grew 2% (OTC high teens, Medico single-digit).
- Category-wise reporting introduced, replacing brand-wise disclosure, to reflect portfolio diversification and scale.
Analyst Q&A
Q. Sustainability of 61% like-to-like growth in strategic investments
Growth is across all four subsidiaries, driven by initiatives and is quite sustainable; Axiom saw rewards from work since 2023, TMC grew north of 20%, no one-offs.
Q. Rationale for category-based reporting mixing seasonal talc with male grooming and BoroPlus, and Zandu pain management with healthcare
With many brands it is not possible to give brand-wise information; Zandu Balm is healthcare and brand name is Zandu, so it is clubbed; seasonal confusion is overstated.
Q. Margin outlook ex-strategic investments and operating margin range expectation
Margin pressure is short-term due to West Asia conflict; once settled we have to wait and see; confident margins won’t come down but no specific range given.
Q. One-timeఇని high other income in standalone numbers
Includes a dividend of roughly ₹32 Cr from an international subsidiary, eliminated on consolidation.
Research and educational content only. Not investment advice.